Test Directory
Platelet Aggregation – Aspirin Sensitivity
Justification
Aspirin (acetylsalicylic acid) is commonly prescribed as an antiplatelet agent for the prevention of arterial thrombosis in conjunction with Plavix. Aspirin is a COX-1 inhibitor and reduces the production of thromboxane A2 (TXA2), a vasoconstrictor and activator of platelets, in activated platelets, interrupting the positive feedback loop.
Aspirin sensitivity testing by platelet aggregometry can be used to assess the effectiveness of platelet inhibition by aspirin therapy or restoration of platelet function after discontinuation of aspirin.
STAT: < 24 hours (M-F)
Light Transmittance Aggregometry (LTA)
Draw Tube: Blue Top
Sample Type: Citrated Whole Blood
Specimen Requirements
Sample Type | Volume Required | Minimum Volume | Stability | |
---|---|---|---|---|
PREFERRED | Citrated Whole Blood | Four tubes, 3mL each (or equivalent volume) | For pediatric minimum, please call (800) 566-3462. | Room Temperature: 4 hours
By appointment only - must arrive at lab within 2 hours of draw |
ALTERNATIVE | - | - | - | - |
REJECTION CRITERIA | Samples received more than 2 hours after draw |
SPECIAL INSTRUCTIONS | See Draw Guide By appointment only |
General Information
METHODOLOGY | Light Transmittance Aggregometry (LTA) |
STAT TAT | < 24 hours (M-F) |
STAT TAT Performance | > 90% of results released in 24 hours |
ROUTINE TAT | < 24 hours (M-F) |
ALTERNATIVE NAMES | Platelet Aggregation - ASA, Aspirin Sensitivity |
DESCRIPTION | Platelet aggregation is measured in response to Arachidonic Acid and control agonists by light transmittance aggregometry (LTA). A significant reduction in platelet aggregation in response to Arachidonic Acid is expected with successful aspirin therapy. |
LIMITATIONS | Hemolytic, Icteric, and Lipemic samples |
NORMAL RANGE | Interpretation |
ASSOCIATED TESTING | - |
REFERENCES | - |
SAMPLE REPORT | Upon request |
NEW YORK STATE APPROVED | - |
Test Codes
ORDER CODE | P3029 |
CPT CODE | 85576x4 |
LOINC CODE | 53568-2 |